Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 29%
Buy 57%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

UnitedHealth Group is well-positioned in the healthcare industry with a diverse portfolio and strong management. Despite potential challenges, such as changes in medical costs and regulatory risks, the company's recent earnings and technology-driven initiatives have resulted in a positive outlook and raised price target. With a growing Optum division, UnitedHealth Group is a recommended investment with potential for continued growth.

Bears say

UnitedHealth Group is a leading player in the health insurance industry, but the company's high medical cost trends pose a significant risk to its financial performance. While the Medicare Advantage business has been performing well and driving overall growth, the company's commercial business is facing challenges due to disputes with out-of-network providers and a more general trend of rising healthcare costs. Despite its strong scale and impressive growth targets, UnitedHealth Group's financials may be limited by the high medical costs seen in recent years and the ongoing challenges in the commercial segment.

UnitedHealth Group (UNH) has been analyzed by 21 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 21 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Sep 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $454.76, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $454.76, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.